4//SEC Filing
Hadfield Robert 4
Accession 0001209191-19-002782
CIK 0001107421other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 4:25 PM ET
Size
7.3 KB
Accession
0001209191-19-002782
Insider Transaction Report
Form 4
Hadfield Robert
General Counsel and Secretary
Transactions
- Award
Employee Stock Option (right to buy)
2019-01-06+185,391→ 185,391 totalExercise: $2.24Exp: 2029-01-06→ Common Stock (185,391 underlying) - Award
Common Stock
2019-01-06+117,572→ 117,572 total
Footnotes (2)
- [F1]39,191 shares shall vest on each of 12/31/2019 and 12/31/2020, and 39,190 shares shall vest on 12/31/2021.
- [F2]1/12th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2018.
Documents
Issuer
ZIOPHARM ONCOLOGY INC
CIK 0001107421
Entity typeother
Related Parties
1- filerCIK 0001630687
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 4:25 PM ET
- Size
- 7.3 KB